Sputnik V Mumbai gets three bids from Russia's Sputnik V vaccine developers
New Delhi/IBNS: Mumbai on Monday received three bids for the supply of Russia's Sputnik V COVID vaccine, media reports said.
This is in response to Brihanmumbai Municipal Corporation (BMC)'s tenders on May 11.
These tenders were issued under the country's latest nationwide COVID-19 inoculation policy, allowing state governments to procure Covid vaccine doses directly from producers.
The deadline for submission of bids ends on Tuesday.
Of the three received till now, one was made directly by the Russian Direct Investment Fund (RDIF) and the other two by its independent representatives, NDTV quoting sources said.
Sputnik V has been developed by Gamaleya Research Institute of Epidemiology and Microbiology in Russia.
It was approved by the Indian government for use in the country alongside two indigenous vaccines-Covaxin and Covishield.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
